...
机译:oA 16.08基于来自10至14级的N1节点的系统解剖的改良病理N1分类策略,用于非小细胞肺癌
Department of Thoracic Surgery II Peking University Cancer Hospital &
Institute Key Laboratory of;
Department of Thoracic Surgery II Peking University Cancer Hospital &
Institute Key Laboratory of;
Department of Thoracic Surgery II Peking University Cancer Hospital &
Institute Key Laboratory of;
Department of Thoracic Surgery II Peking University Cancer Hospital &
Institute Key Laboratory of;
Department of Thoracic Surgery II Peking University Cancer Hospital &
Institute Key Laboratory of;
Department of Thoracic Surgery II Peking University Cancer Hospital &
Institute Key Laboratory of;
Department of Thoracic Surgery II Peking University Cancer Hospital &
Institute Key Laboratory of;
Department of Thoracic Surgery II Peking University Cancer Hospital &
Institute Key Laboratory of;
机译:oA 16.08基于来自10至14级的N1节点的系统解剖的改良病理N1分类策略,用于非小细胞肺癌
机译:非小细胞肺癌的病理性N1疾病的手术结果和预后因素:N1水平的意义:大叶或肺门淋巴结转移
机译:N1淋巴结清扫术后辅助化疗可改善非小细胞肺癌伴肺内淋巴结转移的患者预后
机译:切除类型对N1非小细胞肺癌患者生存的影响
机译:非小细胞肺癌细胞中TWEAK受体(Fn14)表达和功能的分析。
机译:淋巴结比率在病理性N1非小细胞肺癌患者中的预后价值:一项荟萃分析的系统评价
机译:oA 16.08基于来自10至14级的N1节点的系统解剖的改良病理N1分类策略,用于非小细胞肺癌